TW

Tom Woiwode

Managing Director at Versant Ventures

San Francisco, California

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Education

Work Experience

  • Managing Director

    2014

  • Venture Partner

    2005 - 2014

    Served in key roles in several portfolio companies and managed Versant's expansion into Europe.

  • Associate/Principal

    2002 - 2005

Okairos

2011 - 2013

  • Chief Operating Officer

    2011 - 2013

    Okairos was acquired by GSK for $325M in May 2013.

Flexion

2008 - 2010

  • Chief Business Officer

    2008 - 2010

    Flexion completed an Initial Public Offering in February 2014.

Synosia

2006 - 2008

  • Chief Business Officer

    2006 - 2008

    Synosia was acquired by BioTie in January 2011.

Amira

2005 - 2006

  • Chief Business Officer

    2005 - 2006

    Amira was acquired by BMS for up to $475M in September 2011.

XenoPort

2000 - 2002

  • Research Scientist

    2000 - 2002